Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Foghorn Therapeutics Inc. (FHTX)
Company Research
Source: Yahoo! Finance
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FHTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FHTX alerts
High impacting Foghorn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
FHTX
News
- Foghorn Therapeutics to Participate in Two Upcoming Investor ConferencesGlobeNewswire
- Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial OfficerGlobeNewswire
- Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..MarketBeat
- Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech SummitGlobeNewswire
- Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% PremiumGlobeNewswire
FHTX
Earnings
- 11/5/25 - Beat
FHTX
Sec Filings
- 2/24/26 - Form 4
- 2/24/26 - Form 3
- 2/23/26 - Form 8-K
- FHTX's page on the SEC website